RXRX
NASDAQ · Biotechnology
Recursion Pharmaceuticals-A
$3.22
+0.04 (+1.26%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-19.10%
1Y
-39.93%
YTD
-23.33%
Open$3.25
Previous Close$3.18
Day High$3.27
Day Low$3.18
52W High$7.18
52W Low$2.77
Volume—
Avg Volume17.49M
Market Cap1.73B
P/E Ratio—
EPS$-1.20
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$4.31
Below
SMA 200
$4.89
Below
RSI (14)
34.7
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Buy
14 analysts
Price Target
+797.5% upside
Current
$3.22
$3.22
Target
$28.90
$28.90
$21.05
$28.90 avg
$39.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 90.06M | 73.04M | 309.68M |
| Net Income | -777,596,472 | -567,588,665 | -18,426,824 |
| Profit Margin | -863.4% | -820.2% | -6.0% |
| EBITDA | -732,699,854 | -564,529,490 | -21,116,374 |
| Free Cash Flow | — | — | -13,211,156 |
| Rev Growth | +23.3% | +23.3% | +0.8% |
| Debt/Equity | 0.02 | 0.02 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |